This report provides a comprehensive analysis of the global Quetiapine Fumarate Tablets market, focusing on its role in treating mental health conditions like schizophrenia and bipolar disorder. It evaluates market dynamics, growth drivers, and competitive landscapes across key regions, including the United States, China, and Europe. Through detailed segmentation by dosage type and application, the study examines the strategies of major players such as AstraZeneca and Teva Pharmaceuticals to identify emerging opportunities and future market trajectories.

Market Overview

The global Quetiapine Fumarate Tablets market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Product Profile

Quetiapine is an antipsychotic medication utilized in the treatment of various mental health conditions, including schizophrenia and bipolar disorder. The medication functions by balancing dopamine and serotonin levels in the brain, which are hormones essential for regulating mood, behaviors, and thoughts.

Regional Market Analysis

• United States: The market for Quetiapine Fumarate Tablets in the United States is expected to see an increase from 2025 through 2032, maintaining a consistent growth rate.
• China: The Chinese market for Quetiapine Fumarate Tablets is projected to expand between 2025 and 2032 at a steady compound annual growth rate.
• Europe: The European market for Quetiapine Fumarate Tablets is estimated to grow from 2025 to 2032, following a positive growth trajectory.

Market Segmentation

By Type

• 0.2g
• 0.3g
• Others

By Application

• Hospital
• Clinic
• Others

By Geography

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• AstraZeneca
• Teva Pharmaceuticals
• Sun Pharma
• Sandoz
• Lupin Limited
• Hikma
• Dr. Reddy's Laboratories
• Alkem Laboratories
• Hunan Dongting Pharmaceutical

Market Dynamics

In 2025, the two largest global companies held a significant portion of the market share. This report provides a comprehensive analysis of the global landscape, highlighting key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

The report also examines the strategies of leading global companies, focusing on their Quetiapine Fumarate Tablets portfolios, capabilities, market entry strategies, market positions, and geographic footprints to understand their unique standing in an accelerating global market.

Research Methodology & Scope

This newest research report from LP Information, Inc. (LPI), titled “Quetiapine Fumarate Tablets Industry Forecast,” reviews total global sales for 2025 and provides a comprehensive analysis of projected sales for the period of 2026 through 2032.

Key features of the report include:

• Detailed Breakdown: Sales analysis provided by region, market sector, and sub-sector in US$ millions.
• Comprehensive Evaluation: Assessment of key market trends, drivers, and affecting factors shaping the global outlook.
• Opportunity Identification: Forecasts broken down by Type, Application, geography, and market size to highlight emerging pockets of opportunity.
• Transparent Methodology: A nuanced view of the current state and future trajectory based on hundreds of bottom-up qualitative and quantitative market inputs.

Key Questions Addressed

• What is the 10-year outlook for the global Quetiapine Fumarate Tablets market?
• What factors are driving Quetiapine Fumarate Tablets market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Quetiapine Fumarate Tablets market opportunities vary by end market size?
• How does Quetiapine Fumarate Tablets break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Quetiapine Fumarate Tablets Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Quetiapine Fumarate Tablets by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Quetiapine Fumarate Tablets by Country/Region, 2021, 2025 & 2032

  • 2.2 Quetiapine Fumarate Tablets Segment by Type

    • 2.2.1 0.2g

    • 2.2.2 0.3g

    • 2.2.3 Others

    • 2.2.4 Quetiapine Fumarate Tablets Sales by Type

      • 2.2.4.1 Global Quetiapine Fumarate Tablets Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Quetiapine Fumarate Tablets Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Quetiapine Fumarate Tablets Sale Price by Type (2021-2026)

  • 2.3 Quetiapine Fumarate Tablets Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Others

    • 2.3.4 Quetiapine Fumarate Tablets Sales by Application

      • 2.3.4.1 Global Quetiapine Fumarate Tablets Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Quetiapine Fumarate Tablets Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Quetiapine Fumarate Tablets Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Quetiapine Fumarate Tablets Breakdown Data by Company

    • 3.1.1 Global Quetiapine Fumarate Tablets Annual Sales by Company (2021-2026)

    • 3.1.2 Global Quetiapine Fumarate Tablets Sales Market Share by Company (2021-2026)

  • 3.2 Global Quetiapine Fumarate Tablets Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Quetiapine Fumarate Tablets Revenue by Company (2021-2026)

    • 3.2.2 Global Quetiapine Fumarate Tablets Revenue Market Share by Company (2021-2026)

  • 3.3 Global Quetiapine Fumarate Tablets Sale Price by Company

  • 3.4 Key Manufacturers Quetiapine Fumarate Tablets Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Quetiapine Fumarate Tablets Product Location Distribution

    • 3.4.2 Players Quetiapine Fumarate Tablets Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Quetiapine Fumarate Tablets by Geographic Region

  • 4.1 World Historic Quetiapine Fumarate Tablets Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Quetiapine Fumarate Tablets Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Quetiapine Fumarate Tablets Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Quetiapine Fumarate Tablets Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Quetiapine Fumarate Tablets Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Quetiapine Fumarate Tablets Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Quetiapine Fumarate Tablets Sales Growth

  • 4.4 APAC Quetiapine Fumarate Tablets Sales Growth

  • 4.5 Europe Quetiapine Fumarate Tablets Sales Growth

  • 4.6 Middle East & Africa Quetiapine Fumarate Tablets Sales Growth

• 5 Americas

  • 5.1 Americas Quetiapine Fumarate Tablets Sales by Country

    • 5.1.1 Americas Quetiapine Fumarate Tablets Sales by Country (2021-2026)

    • 5.1.2 Americas Quetiapine Fumarate Tablets Revenue by Country (2021-2026)

  • 5.2 Americas Quetiapine Fumarate Tablets Sales by Type (2021-2026)

  • 5.3 Americas Quetiapine Fumarate Tablets Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Quetiapine Fumarate Tablets Sales by Region

    • 6.1.1 APAC Quetiapine Fumarate Tablets Sales by Region (2021-2026)

    • 6.1.2 APAC Quetiapine Fumarate Tablets Revenue by Region (2021-2026)

  • 6.2 APAC Quetiapine Fumarate Tablets Sales by Type (2021-2026)

  • 6.3 APAC Quetiapine Fumarate Tablets Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Quetiapine Fumarate Tablets by Country

    • 7.1.1 Europe Quetiapine Fumarate Tablets Sales by Country (2021-2026)

    • 7.1.2 Europe Quetiapine Fumarate Tablets Revenue by Country (2021-2026)

  • 7.2 Europe Quetiapine Fumarate Tablets Sales by Type (2021-2026)

  • 7.3 Europe Quetiapine Fumarate Tablets Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Quetiapine Fumarate Tablets by Country

    • 8.1.1 Middle East & Africa Quetiapine Fumarate Tablets Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Quetiapine Fumarate Tablets Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Quetiapine Fumarate Tablets Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Quetiapine Fumarate Tablets Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Quetiapine Fumarate Tablets

  • 10.3 Manufacturing Process Analysis of Quetiapine Fumarate Tablets

  • 10.4 Industry Chain Structure of Quetiapine Fumarate Tablets

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Quetiapine Fumarate Tablets Distributors

  • 11.3 Quetiapine Fumarate Tablets Customer

• 12 World Forecast Review for Quetiapine Fumarate Tablets by Geographic Region

  • 12.1 Global Quetiapine Fumarate Tablets Market Size Forecast by Region

    • 12.1.1 Global Quetiapine Fumarate Tablets Forecast by Region (2027-2032)

    • 12.1.2 Global Quetiapine Fumarate Tablets Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Quetiapine Fumarate Tablets Forecast by Type (2027-2032)

  • 12.7 Global Quetiapine Fumarate Tablets Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 AstraZeneca

    • 13.1.1 AstraZeneca Company Information

    • 13.1.2 AstraZeneca Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.1.3 AstraZeneca Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 AstraZeneca Main Business Overview

    • 13.1.5 AstraZeneca Latest Developments

  • 13.2 Teva Pharmaceuticals

    • 13.2.1 Teva Pharmaceuticals Company Information

    • 13.2.2 Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.2.3 Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Teva Pharmaceuticals Main Business Overview

    • 13.2.5 Teva Pharmaceuticals Latest Developments

  • 13.3 Sun Pharma

    • 13.3.1 Sun Pharma Company Information

    • 13.3.2 Sun Pharma Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.3.3 Sun Pharma Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Sun Pharma Main Business Overview

    • 13.3.5 Sun Pharma Latest Developments

  • 13.4 Sandoz

    • 13.4.1 Sandoz Company Information

    • 13.4.2 Sandoz Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.4.3 Sandoz Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Sandoz Main Business Overview

    • 13.4.5 Sandoz Latest Developments

  • 13.5 Lupin Limited

    • 13.5.1 Lupin Limited Company Information

    • 13.5.2 Lupin Limited Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.5.3 Lupin Limited Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Lupin Limited Main Business Overview

    • 13.5.5 Lupin Limited Latest Developments

  • 13.6 Hikma

    • 13.6.1 Hikma Company Information

    • 13.6.2 Hikma Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.6.3 Hikma Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Hikma Main Business Overview

    • 13.6.5 Hikma Latest Developments

  • 13.7 Dr. Reddy's Laboratories

    • 13.7.1 Dr. Reddy's Laboratories Company Information

    • 13.7.2 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.7.3 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Dr. Reddy's Laboratories Main Business Overview

    • 13.7.5 Dr. Reddy's Laboratories Latest Developments

  • 13.8 Alkem Laboratories

    • 13.8.1 Alkem Laboratories Company Information

    • 13.8.2 Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.8.3 Alkem Laboratories Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Alkem Laboratories Main Business Overview

    • 13.8.5 Alkem Laboratories Latest Developments

  • 13.9 Hunan Dongting Pharmaceutical

    • 13.9.1 Hunan Dongting Pharmaceutical Company Information

    • 13.9.2 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolios and Specifications

    • 13.9.3 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Hunan Dongting Pharmaceutical Main Business Overview

    • 13.9.5 Hunan Dongting Pharmaceutical Latest Developments

• 14 Research Findings and Conclusion